NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of common stocks ofU. S. pharmaceutical companies.
These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 5.43% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 5.36% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.31% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 5.15% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.92% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.83% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.73% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.68% |
| BHC | Bausch Health Companies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
| ANIP | ANI Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.86% |
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 3.64% |
| TARO | Taro Pharmaceutical Industries Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 3.59% |
| PCRX | Pacira BioSciences, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 3.20% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 3.18% |
| INVA | Innoviva Inc | Healthcare | Biotechnology | 3.14% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 2.99% |
| COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.89% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.86% |
| PBH | Prestige Brand Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.78% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 2.73% |